P-Cresol

P-Cresol

SCHEMBL1229546

Cc1ccc([O-])cc1.Cc1ccc([O-])cc1.Cc1ccc([O-])cc1.Cc1ccc([O-])cc1.[Ti+4]

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 7/20 0.57
TDP1 Q9NUW8 1/20 0.57
CA2 P00918 3/20 0.43
LPL P06858 1/20 0.43
LIPG Q9Y5X9 1/20 0.43
ORAI1 Q96D31 1/20 0.43
ORAI2 Q96SN7 1/20 0.43
ORAI3 Q9BRQ5 1/20 0.43
TRPV6 Q9H1D0 1/20 0.43
GAA P10253 1/20 0.43
ALDH1A1 P00352 3/20 0.42
CA1 P00915 2/20 0.42
CA7 P43166 2/20 0.42
CA9 Q16790 2/20 0.42
HSD17B10 Q99714 1/20 0.39
CA12 O43570 1/20 0.39
CA3 P07451 1/20 0.39
CA6 P23280 1/20 0.39
CA5A P35218 1/20 0.39
CA5B Q9Y2D0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
P-Cresol SCHEMBL8157029 0.93 ACHE (0.57) ACHETDP1CA2LPLLIPG
P-Cresol SCHEMBL1229426 0.93 ACHE (0.57) ACHETDP1CA2LPLLIPG
P-Cresol SCHEMBL585061 0.93
P-Cresol SCHEMBL10728842 0.93 ACHE (0.57) ACHETDP1CA2LPLLIPG
P-Cresol SCHEMBL6063969 0.93 ACHE (0.57) ACHETDP1CA2LPLLIPG
P-Cresol SCHEMBL585475 0.93
P-Cresol SCHEMBL8423863 0.93 ACHE (0.57) ACHETDP1CA2LPLLIPG
P-Cresol SCHEMBL585229 0.93
P-Cresol SCHEMBL1228560 0.93 ACHE (0.57) ACHETDP1CA2LPLLIPG
P-Cresol SCHEMBL6039896 0.90 ACHE (0.53) ACHETDP1CA2LPLLIPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12623999-B2 Carbamate production method, carbamate ester production method, and urea derivative production method NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2026-05-12 US disclosed
US-20230212110-A1 CARBAMATE PRODUCTION METHOD, CARBAMATE ESTER PRODUCTION METHOD, AND UREA DERIVATIVE PRODUCTION METHOD NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2023-07-06 US disclosed
EP-4169901-A1 CARBAMATE PRODUCTION METHOD, CARBAMATE ESTER PRODUCTION METHOD, AND UREA DERIVATIVE PRODUCTION METHOD National Institute Of Advanced Industrial Science and Technology (JP) 2023-04-26 EP disclosed
EP-3575706-B1 ABSORBER COATING FOR SOLAR THERMAL POWER GENERATION AND PROCESS FOR PRODUCING SAID COATING NANO FRONTIER TECH CO LTD (JP) 2022-07-27 EP disclosed
EP-3363780-B1 USE OF DIARYL CARBONATE, METHOD OF PRODUCING THE SAME, AND METHOD FOR PRODUCING AROMATIC POLYCARBONATE RESIN MITSUBISHI GAS CHEMICAL CO (JP) 2022-07-06 EP disclosed
CN-110913982-B Oligomerization process using a reaction apparatus comprising a dispersion member IFP 新能源公司 2022-05-24 CN disclosed
US-11207657-B2 Oligomerization method using a reaction device comprising a dispersion means IFP Energies Nouvelles (FR) 2021-12-28 US disclosed
US-11142506-B2 Diaryl carbonate and method for producing the same, and method for producing an aromatic polycarbonate resin MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-10-12 US disclosed
EP-2837660-B1 CURABLE COMPOSITION, AND CURED SYNTHETIC RESIN USING SAME UNIV MIE (JP) 2021-07-14 EP disclosed
US-11002466-B2 Absorber coating for solar heat power generation and manufacturing method thereof NANO FRONTIER TECHNOLOGY CO., LTD. 2021-05-11 US disclosed
EP-1749858-A1 CURABLE COMPOSITION Kaneka Corporation (JP) 2007-02-07 EP disclosed
EP-1749857-A1 CURABLE COMPOSITION Kaneka Corporation (JP) 2007-02-07 EP disclosed
EP-1746134-A1 CURABLE COMPOSITION WITH IMPROVED CURABILITY AND ADHESIVENESS Kaneka Corporation (JP) 2007-01-24 EP disclosed
EP-1746135-A1 CURABLE COMPOSITION Kaneka Corporation (JP) 2007-01-24 EP disclosed
EP-1746133-A1 CURABLE COMPOSITION IMPROVED IN ADHESIVENESS Kaneka Corporation (JP) 2007-01-24 EP disclosed
EP-0760359-B1 Method for preparing aromatic carbonate MITSUBISHI GAS CHEMICAL CO (JP) 1999-10-20 EP disclosed
US-5714627-A REACTING A DIALKYL CARBONATE WITH AN AROMATIC CARBOXYLIC ACID ARYL ESTER IN THE PRESENCE OF A CATALYST MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1998-02-03 US disclosed
EP-0760359-A1 Method for preparing aromatic carbonate MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1997-03-05 EP disclosed
EP-0103120-A2 Process for producing a catalyst component used for the polymerization of alpha-olefins TOYO STAUFFER CHEMICAL CO. LTD. (JP) 1984-03-21 EP disclosed
EP-0102503-A2 Process for producing a catalyst component used for the polymerization of alpha-olefins TOYO STAUFFER CHEMICAL CO. LTD. (JP) 1984-03-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11207657-B2 Oligomerization method using a reaction device comprising a dispersion means NOD1, NOD2, OXER1 ACHE 604/4885TDP1 176/4885CA2 4685/4885
US-12623999-B2 Carbamate production method, carbamate ester production method, and urea derivative production method CPS1, CA2, CHRM2 ACHE 1476/4885TDP1 2886/4885CA2 2/4885
US-20230212110-A1 CARBAMATE PRODUCTION METHOD, CARBAMATE ESTER PRODUCTION METHOD, AND UREA DERIVATIVE PRODUCTION METHOD CPS1, ATM, OAT ACHE 372/4885TDP1 732/4885CA2 11/4885
US-11142506-B2 Diaryl carbonate and method for producing the same, and method for producing an aromatic polycarbonate resin ASH2L, DOT1L, DCXR ACHE 2658/4885TDP1 2406/4885CA2 375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.